Back to signals
FDA device recallVulnerabilitiesPublished May 11, 2026

Dexcom, Inc.: Integrated Continuous Glucose Monitoring System, Factory Calibrated

A software defect in which a low-priority file I/O check blocks the higher-priority thread responsible for processing estimated glucose values (EGVs) and trend arrows. When the app is running in the background, EGV notifications may queue up and then "replay" sequentially when the user brings the app to the foreground, causing the Glucose Compass to flicker through previous EGVs. In more severe instances, the app may perceive signal loss and deploy signal loss mitigations. This delay in EGV and alert processing creates a risk that users may miss detection of a hypoglycemic or hyperglycemic event, or make treatment decisions based on outdated glucose information.

Open the source record
Tags
FDA recall, medical device, class 2, Clinical Chemistry, Software design, Open, Classified
Related exam domains
CISSP 3: Security Architecture and Engineering; CISSP 7: Security Operations; CISSP 8: Software Development Security; CISM 2: Information Security Risk Management
Source record id
Z-2165-2026
First seen by InfoSec Signals
9/23/2026

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.